Global /China /Healthcare /Drug Manufacturers - General /688189

Hunan Nucien Pharmaceutical Co., Ltd.

688189

• SSE: 688189 • Delayed

8.95CNY 11%

1.32 USD

As of 14 June 2026, Hunan Nucien Pharmaceutical Co., Ltd. has a market cap of $360.01M USD, ranking #17418 globally and #5406 in China. It ranks #1577 in the Healthcare sector, and #567 in the Drug Manufacturers - General industry.

Global Rank

17418

Country Rank

5406

Sector Rank

1577

Industry Rank

567

Key Stats

Market Cap

$360.01MUSD

2.44B CNY

Enterprise Value

$306.89MUSD

2.08B CNY

Revenue (TTM)

$20.95MUSD

141.93M CNY

EBITDA (TTM)

-$6.29MUSD

-42.57M CNY

Net Income (TTM)

-$20.2MUSD

-136.9M CNY

EBITDA Margin

-30%

Profit Margin

-96%

PS Ratio

17.2

PB Ratio

3.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Shi Xi Zhang open_in_new

Employees

319

Founded

2006

Website

nucien.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
11%	7.8%	4.4%	-6%	-5.1%	0.8%	35%	-23%	-62%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	688189 ISIN: CNE100007713 Shares Out.: Shares Outstanding: 270.541M¹ Shares Float: 270.529M² TV: TradingView: SSE: 688189 SA: Stock Analysis: SHA: 688189 YF: Yahoo Finance: 688189.SS GF: Google Finance: SHA: 688189 BA: Barron's: 688189 MS: Morningstar: XSHG: 688189	8.95 CNY	TV: TradingView: SSE: 688189 SA: Stock Analysis: SHA: 688189 YF: Yahoo Finance: 688189.SS GF: Google Finance: SHA: 688189 BA: Barron's: 688189 MS: Morningstar: XSHG: 688189

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Hunan Nucien Pharmaceutical Co., Ltd.

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceutical Co., Ltd. was founded in 2006 and is based in Guangzhou, China.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.85B 364.89B CNY 15K%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.64B 336.36B CNY 14K%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 8K%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 5K%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.51B 111.89B CNY 4K%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 4K%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 211K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 152K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 100K%	97.4	United States
Roche Holding AG SIX: RO	$321.52B 256.25B CHF 89K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$288.84B 215.59B GBP 80K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$274.65B 218.9B CHF 76K%	20.5	Switzerland

chevron_leftBack